Original Article
Syncope in children: Diagnostic tests have a high cost and low yield

https://doi.org/10.1016/j.jpeds.2004.10.039Get rights and content

Objectives

To assess the use, yield, and cost-effectiveness of diagnostic tests used in the evaluation of syncope in children.

Study design

A retrospective review of 169 pediatric patients presenting to a tertiary care center with new onset syncope was undertaken. Test results were considered diagnostic when an abnormal result correlated with the clinical diagnosis or a normal result was obtained during a syncopal episode. Costs were based on the hospital cost of testing for fiscal year 1999, using a relative value unit–based costing methodology and did not include professional fees or costs of hospitalization.

Results

A total of 663 tests were performed at a cost of $180,128. Only 26 tests (3.9%) were diagnostic in 24 patients (14.2%). The average cost per patient was $1055, and the cost per diagnostic result was $6928. Echocardiograms, chest radiographs, cardiac catheterizations, electrophysiology studies, and serum evaluations were not diagnostic.

Conclusions

The evaluation of pediatric syncope remains expensive, and testing has a low diagnostic yield. An approach that focuses on the use of testing to verify findings from the history and physical examination or exclude life-threatening causes is justified.

Section snippets

Methods

Patients presenting to the hospital or clinics for evaluation of syncope between January 1, 1998, and December 31, 1999, were identified from hospital billing records. Subjects between 4 and 18 years of age were included if they underwent an initial evaluation for episodes characterized by transient loss of consciousness associated with loss of postural tone. Patients were excluded if their presenting episode was diagnosed as a seizure at the initial visit or if the episode was characteristic

Patients

Patients who met the inclusion criteria (n = 169; 99 female) ranged in age from 4.5 to 18.7 years (mean, 13.2 ± 3.6). The follow-up period ranged from 122 to 768 days (mean, 312 ± 129).

Several patients had preexisting conditions that may have affected their evaluation. Three patients had congenital heart disease, and 1 patient had a family history of hypertrophic cardiomyopathy. Preexisting neurologic disorders were present in 9 patients, including 3 patients with a history of seizures.

Discussion

Multiple studies have documented the limited utility of laboratory testing in adult populations with syncope, particularly when not guided by the history and physical examination.4, 5, 6 Limited data are available in children, but other small studies have reported a high cost and low yield.3, 7 Our study confirms this finding, as demonstrated in Figure 2. The disparity in the numbers of each test performed is displayed in the denominator of the fraction above each test. The cost per diagnostic

Limitations

This study is subject to several limitations. The group may not be representative of patients evaluated in a primary care setting or other tertiary care centers. The costs of individual tests may be different at other centers and the yield of tests may differ. Also, the study does not account for the validity of the clinical impression. In some patients, test results were abnormal but no diagnosis was established. Since the effectiveness of each test was judged against each patient's diagnosis,

Conclusions

The evaluation of syncope remains costly, and the majority of tests demonstrate a low diagnostic yield. Often, a diagnosis can be established without a positively correlating test result. Since most tests are unlikely to produce diagnostic results, an approach that focuses on the use of testing primarily to corroborate findings from the history and physical examination and to identify life-threatening diseases may be warranted. The results of this study are consistent with previous findings in

References (21)

  • W.N. Kapoor et al.

    Syncope of unknown origin: the need for a more cost-effective approach to its diagnosis evaluation

    JAMA

    (1982)
  • H. Calkins et al.

    The economic burden of unrecognized vasodepressor syncope

    Am J Med

    (1993)
  • T.A. Gordon et al.

    A retrospective analysis of the cost-effective workup of syncope in children

    Cleve Clin J Med

    (1987)
  • W.N. Kapoor

    Evaluation and outcome of patients with syncope

    Medicine (Baltimore)

    (1990)
  • S.C. Day et al.

    Evaluation and outcome of emergency room patients with transient loss of consciousness

    Am J Med

    (1982)
  • K.A. Eagle et al.

    The impact of diagnostic tests in evaluating patients with syncope

    Yale J Biol Med

    (1983)
  • T. Lerman-Sagie et al.

    A prospective evaluation of pediatric patients with syncope

    Clin Pediatr (Phila)

    (1994)
  • M. Linzer et al.

    Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope

    Am J Cardiol

    (1990)
  • S.R. Cumbee et al.

    Cardiac loop ECG recording: a new noninvasive diagnostic test in recurrent syncope

    South Med J

    (1990)
  • A.P. Brown et al.

    Detection of arrhythmias: use of a patient-activated ambulatory electrocardiogram device with a solid-state memory loop

    Br Heart J

    (1987)
There are more references available in the full text version of this article.

Cited by (89)

  • Pediatric Appropriate Use Criteria for Outpatient Echocardiography: Practice Variations among Pediatric Cardiologists, Noncardiologist Subspecialists, and Primary Care Providers

    2017, Journal of the American Society of Echocardiography
    Citation Excerpt :

    Our cohort provides further insight into the diagnostic yield of specific indications that were commonly used. Prior publications have illustrated diagnostic value of routine TTE for general pediatric referrals that varies from 20% to 32% for heart murmur20-23 to <5% for chest pain24 and syncope.25,26 When focusing on the individual A or M referrals within the indication table, we uncovered cardiac pathology in 40% of referrals for pathologic murmur and in 15% for exertional chest pain.

View all citing articles on Scopus
View full text